Skip to main content


Page 2 of 5

  1. Few studies have evaluated weight change in patients who initiate medical marijuana treatment to address diagnosed health concerns. The objective of this study was to examine whether patients initiating medica...

    Authors: Michelle R. Lent, Meghan Visek, Paulina Syracuse, Karen L. Dugosh and David S. Festinger
    Citation: Journal of Cannabis Research 2022 4:48
  2. An estimated 54 million Americans currently suffer from debilitating arthritis. Patients who have exhausted conservative measures can be subject to chronic pain and resort to symptomatic management with anti-i...

    Authors: Nicholas Frane, Erik Stapleton, Cesar Iturriaga, Maximillian Ganz, Vijay Rasquinha and Robert Duarte
    Citation: Journal of Cannabis Research 2022 4:47
  3. While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospital...

    Authors: Carolyn M. Shover, Peter Yan, Nicholas J. Jackson, Russell G. Buhr, Jennifer A. Fulcher, Donald P. Tashkin and Igor Barjaktarevic
    Citation: Journal of Cannabis Research 2022 4:46
  4. Industrial hemp, with low levels of the intoxicating cannabinoid tetrahydrocannabinol (THC), is grown for fibre and seeds. The industrial hemp industry is poised for expansion. The legalisation of industrial h...

    Authors: Rachel A. Burton, Mike Andres, Martin Cole, James M. Cowley and Mary Ann Augustin
    Citation: Journal of Cannabis Research 2022 4:45
  5. Cannabinol (CBN) is one of the many cannabinoids present in Cannabis sativa and has been explored as a potential treatment for sleeplessness. The purpose of this study was to determine the physiological and behav...

    Authors: Melissa M. Bailey, Mariah C. Emily Mills, Ashley E. Haas, Kelly Bailey and Robert C. Kaufmann
    Citation: Journal of Cannabis Research 2022 4:44
  6. In 2019, Thailand legalized cannabidiol (CBD) for intractable epilepsy. The purpose of this study was to collect information regarding the experience and knowledge of CBD use in pediatric epilepsy. To the best...

    Authors: Monsicha Ngampoopun, Charcrin Nabangchang and Piradee Suwanpakdee
    Citation: Journal of Cannabis Research 2022 4:43
  7. Several studies have shown anti-tumor effects of components present in cannabis in different models. Unfortunately, little is known about the potential anti-tumoral effects of most compounds present in cannabi...

    Authors: Andrea M. Tomko, Erin G. Whynot and Denis J. Dupré
    Citation: Journal of Cannabis Research 2022 4:41
  8. The purpose of this study is to examine how cannabis legalization and corresponding taxation would affect the supply-side of the cannabis market. Specifically, the study considers various scenarios in which Ok...

    Authors: Joohun Han and John N. Ng’ombe
    Citation: Journal of Cannabis Research 2022 4:40
  9. There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for a few indications, there is a hype about...

    Authors: Arthur Cassa Macedo, André Oliveira Vilela de Faria, Isabella Bizzi, Fabrício A. Moreira, Alessandro Colasanti and Pietro Ghezzi
    Citation: Journal of Cannabis Research 2022 4:37
  10. As a result of the legalization of U.S. industrial hemp production in late 2018, products containing hemp-derived Δ8-tetrahydrocannabinol (Δ8-THC) are increasing in popularity. Little, however, is known regarding...

    Authors: Gregory T. Wurz, Edward Montoya and Michael W. DeGregorio
    Citation: Journal of Cannabis Research 2022 4:36
  11. For a long period, cannabis in Lebanon was categorized as an illegal psychoactive substance criminalized by law, despite being the 3rd largest producer of cannabis resin after Morocco and Afghanistan. The curr...

    Authors: Anthony Mina, Clara Rahme, Souheil Hallit and Michel Soufia
    Citation: Journal of Cannabis Research 2022 4:34
  12. Cannabis sativa has accompanied humankind since ancient times, permeating the most diverse aspects of its existence, among which the search for health promotion and well-being stands out. Nevertheless, during the...

    Authors: Maíra Ribeiro de Souza, Amélia Teresinha Henriques and Renata Pereira Limberger
    Citation: Journal of Cannabis Research 2022 4:33
  13. Patients use medical cannabis for a wide array of illnesses and symptoms, and many substitute cannabis for pharmaceuticals. This substitution often occurs without physician oversight, raising patient safety co...

    Authors: Alexis Holman, Daniel J. Kruger, Philippe Lucas, Kaye Ong, Rachel S. Bergmans and Kevin F. Boehnke
    Citation: Journal of Cannabis Research 2022 4:32
  14. Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial...

    Authors: Tangui Barré, Fabrice Carrat, Clémence Ramier, Hélène Fontaine, Vincent Di Beo, Morgane Bureau, Céline Dorival, Dominique Larrey, Elisabeth Delarocque-Astagneau, Philippe Mathurin, Fabienne Marcellin, Ventzislava Petrov-Sanchez, Carole Cagnot, Patrizia Carrieri, Stanislas Pol and Camelia Protopopescu
    Citation: Journal of Cannabis Research 2022 4:31
  15. Purified cannabidiol (CBD), a non-psychoactive phytocannabinoid, has gained regulatory approval to treat intractable childhood epilepsies. Despite this, artisanal and commercial CBD-dominant hemp-based product...

    Authors: Carol J. Milligan, Lyndsey L. Anderson, Michael T. Bowen, Samuel D. Banister, Iain S. McGregor, Jonathon C. Arnold and Steven Petrou
    Citation: Journal of Cannabis Research 2022 4:30
  16. The relationship between drug use and traumatic injury is well documented, yet only a small proportion of patients are biochemically tested for cannabis and other substances. The study objective was to determi...

    Authors: Kristin Salottolo, Emmett McGuire, Robert Madayag, Allen H. Tanner II, Matthew M. Carrick and David Bar-Or
    Citation: Journal of Cannabis Research 2022 4:29
  17. The legalization of hemp in the USA has led to tremendous growth in the availability of hemp-derived products, particularly cannabidiol (CBD) products. The lack of regulatory oversight in this industry has res...

    Authors: Erin Johnson, Michael Kilgore and Shanna Babalonis
    Citation: Journal of Cannabis Research 2022 4:28
  18. Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several studies in mice and humans have implicated the involvement of t...

    Authors: Jonathan Gorelick, Tal Assa-Glazer, Gil Zandani, Anna Altberg, Noa Sela, Abraham Nyska and Zecharia Madar
    Citation: Journal of Cannabis Research 2022 4:27
  19. Cannabis is increasingly used for medical purposes, particularly in countries like Canada where cannabis was recently legalized for recreational use. We aimed to assess self-medication with cannabis post-canna...

    Authors: Antoine Asselin, Olivier Beauparlant Lamarre, Richard Chamberland, Sarah-Jeanne McNeil, Eric Demers and Arsène Zongo
    Citation: Journal of Cannabis Research 2022 4:26
  20. With increased legalization of cannabis, users are combining cannabis with exercise. The purpose of this study is to understand how and why people use cannabis when participating in physical activity.

    Authors: Whitney L. Ogle, Gregg J. Gold, Lukas E. Coppen and Claire Copriviza
    Citation: Journal of Cannabis Research 2022 4:24
  21. Because cannabinoids are usually amorphous solids, the thought that some of them may also exist in distinctly different crystal polymorphic forms might at first seem unusual. However, this commentary provides ...

    Authors: Crist N. Filer
    Citation: Journal of Cannabis Research 2022 4:23
  22. The Canadian Cannabis Act came into effect on October 17, 2018, which allowed Canadian adults to consume cannabis for non-medical purposes (Government of Canada, Cannabis regulations (SOR/2018-144). Cannabis A...

    Authors: Maisam Najafizada, Arifur Rahman, Jennifer Donnan, Zhihao Dong and Lisa Bishop
    Citation: Journal of Cannabis Research 2022 4:22
  23. Among pathways involved in the pathogenesis of coronavirus disease 2019 (COVID-19), impaired endothelial cell (EC) function and angiogenesis have been discussed less frequently than others such as cytokine sto...

    Authors: Nazanin Ashtar Nakhaei, Andisheh Najarian, Mohammad Hosein Farzaei and Amir Hossein Norooznezhad
    Citation: Journal of Cannabis Research 2022 4:21
  24. The US guidelines recommend avoiding marijuana during breastfeeding given concerns about infant’s neurodevelopment. In this setting, some physicians and hospitals recommend against or prohibit breastfeeding wh...

    Authors: Marielle S. Gross, Margot Le Neveu, Kara A. Milliken and Mary Catherine Beach
    Citation: Journal of Cannabis Research 2022 4:20
  25. Organic solvents are used for manufacturing herbal medicines and can be detected as residues of such processing in the final products. It is important for the safety of consumers to control these solvent resid...

    Authors: Hendrik Jacobus Viviers, Anél Petzer and Richard Gordon
    Citation: Journal of Cannabis Research 2022 4:19
  26. Cannabis social equity programs intend to redress inequities experienced by low income and Black, Indigenous, and People of Color (BIPOC) during cannabis prohibition in the United States. In Los Angeles County...

    Authors: Caislin L. Firth, Kristin M. Warren, Lilian Perez, Beau Kilmer, Regina A. Shih, Joan S. Tucker, Elizabeth J. D’Amico and Eric R. Pedersen
    Citation: Journal of Cannabis Research 2022 4:18
  27. Over-consumption is a common adverse outcome from cannabis edibles. States such as Colorado require each serving of cannabis edible to carry a THC symbol. This study aimed to test whether packaging edibles in ...

    Authors: Samantha Goodman and David Hammond
    Citation: Journal of Cannabis Research 2022 4:17
  28. Cannabis use among pregnant women has increased. We surveyed pregnant women in rural Pennsylvania to examine cannabis use and opinions regarding its safety during pregnancy. We examined associations between ch...

    Authors: Mohamed A. Satti, Eda G. Reed, Elizabeth S. Wenker, Stephanie L. Mitchell, Jay Schulkin, Michael L. Power and A. Dhanya Mackeen
    Citation: Journal of Cannabis Research 2022 4:16
  29. The main biological activities of cannabis are due to the presence of several compounds known as cannabinoids. Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are two of the main cannabinoids. Studies...

    Authors: Tameika R. James, Andrea A. Richards, Dwight A. Lowe, Walton A. Reid, Charah T. Watson and Dagogo J. Pepple
    Citation: Journal of Cannabis Research 2022 4:15
  30. Cannabis legalization has resulted in the proliferation of cannabis products. Participants’ familiarity with terms for these products may have implications for assessment, as unfamiliarity with particular term...

    Authors: S. Berberian, M. L. Broussard, C. Tully, V. Methuku, D. A. Pardini and M. H. Meier
    Citation: Journal of Cannabis Research 2022 4:14
  31. Marijuana (Cannabis sativa) is the most commonly used illicit drug in the USA, and the use of DNA barcodes could assist drug trafficking investigations by indicating the biogeographical origin and crop type of a ...

    Authors: Madeline G. Roman, Ryan Gutierrez and Rachel Houston
    Citation: Journal of Cannabis Research 2022 4:13
  32. Δ9-tetrahydrocannabinol (THC) is the main psychoactive component and one of the most important medicinal compounds in cannabis. Whether in human body fluids and breath or in laboratory and field samples, rapid a....

    Authors: Kaveh Amini, Ali Sepehrifard, Ali Valinasabpouri, Jennifer Safruk, Davide Angelone and Tiago de Campos Lourenco
    Citation: Journal of Cannabis Research 2022 4:12

    The Correction to this article has been published in Journal of Cannabis Research 2022 4:38

  33. We undertook this systematic review to determine the efficacy and safety of cannabis-based medicine as a treatment for behavioral, psychological, and motor symptoms associated with neurocognitive disorders.

    Authors: Anees Bahji, Natasha Breward, Whitney Duff, Nafisa Absher, Scott B. Patten, Jane Alcorn and Darrell D. Mousseau
    Citation: Journal of Cannabis Research 2022 4:11
  34. The current revision to Thailand’s Narcotics Act (B.E. 2563) permits Thai corporations to produce cannabis (ganja) for therapeutic purposes, as well as conduct beneficial research and development in science an...

    Authors: Sarana Rose Sommano, Tibet Tangpao, Tanachai Pankasemsuk, Voranate Ponpanumas, Yuthana Phimolsiripol, Pornchai Rachtanapun and Shashanka K. Prasad
    Citation: Journal of Cannabis Research 2022 4:10
  35. When non-medical cannabis use became legal, government regulators implemented policies to encourage safer consumption through access to a regulated market. While this market is growing, sales still occur throu...

    Authors: Jennifer Donnan, Omar Shogan, Lisa Bishop, Michelle Swab and Maisam Najafizada
    Citation: Journal of Cannabis Research 2022 4:9
  36. The wide heterogeneity of available cannabis products makes it difficult for physicians to appropriately guide patients. In the current study, our objective was to characterize naturalistic cannabis use routin...

    Authors: Kevin F. Boehnke, Laura Yakas, J. Ryan Scott, Melissa DeJonckheere, Evangelos Litinas, Suzanne Sisley, Daniel J. Clauw, David A. Williams and Jenna McAfee
    Citation: Journal of Cannabis Research 2022 4:7
  37. A case of an 85-year-old patient with concurrent use of warfarin and medical cannabis containing delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is described. Warfarin continues to be a cornerstone of...

    Authors: Tyan F. Thomas, Evdokia S. Metaxas, Thu Nguyen, Whitni Bennett, Kathryn V. Skiendzielewski, Diane H. Quinn and Alice L. Scaletta
    Citation: Journal of Cannabis Research 2022 4:6
  38. As the legalization of cannabis moves forward in many countries, it is important to highlight the potential harm that excessive use can cause on young consumers. Crafting effective policy interventions to redu...

    Authors: Salvador Espinosa, Charles Marks and Gustavo Fondevila
    Citation: Journal of Cannabis Research 2022 4:5
  39. Products containing delta-8-THC became widely available in most of the USA following the 2018 Farm Bill and by late 2020 were core products of hemp processing companies, especially where delta-9-THC use remain...

    Authors: Jessica S. Kruger and Daniel J. Kruger
    Citation: Journal of Cannabis Research 2022 4:4
  40. Palliative care aims to improve quality of life through optimal symptom control and pain management. Cannabis-based medicinal products (CBMPs) have a proven role in the treatment of chemotherapy-induced nausea an...

    Authors: Devaki Nimalan, Michal Kawka, Simon Erridge, Mehmet Ergisi, Michael Harris, Oliver Salazar, Rayyan Ali, Katerina Loupasaki, Carl Holvey, Ross Coomber, Michael Platt, James J. Rucker, Shaheen Khan and Mikael H. Sodergren
    Citation: Journal of Cannabis Research 2022 4:3
  41. Cannabigerolic acid (CBGA), a precursor cannabinoid in Cannabis sativa, has recently been found to have anticonvulsant properties in the Scn1a+/- mouse model of Dravet syndrome. Poor brain penetration and chemica...

    Authors: Lyndsey L. Anderson, Michael Udoh, Declan Everett-Morgan, Marika Heblinski, Iain S. McGregor, Samuel D. Banister and Jonathon C. Arnold
    Citation: Journal of Cannabis Research 2022 4:2
  42. Cannabis sativa L. produces at least 120 cannabinoids. Although genetic variation is the main factor in cannabinoid production, the effects of short-term environmental stresses in the early flowering stage remain...

    Authors: Sang-Hyuck Park, Christopher S. Pauli, Eric L. Gostin, S. Kyle Staples, Dustin Seifried, Chad Kinney and Brian D. Vanden Heuvel
    Citation: Journal of Cannabis Research 2022 4:1
  43. Autism spectrum disorder is a neurodevelopmental disorder characterized by deficits in communication, social interaction, restricted interest, and repetitive behaviors. Although more cases are being diagnosed,...

    Authors: Serap Bilge and Barış Ekici
    Citation: Journal of Cannabis Research 2021 3:53

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    3.4 - 5-year Impact Factor
    0.741 - SNIP (Source Normalized Impact per Paper)

    2022 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    302 days submission to accept (Median)

    2022 Usage 
    3,864 Altmetric mentions